中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
19期
28-28,29
,共2页
细菌耐药%大肠埃希菌
細菌耐藥%大腸埃希菌
세균내약%대장애희균
Drug resistance%Escherichia coli
目的：从儿童体内分离大肠埃希菌，并分析其耐药状况。方法本实验中从未满18周岁儿童体内分离出123例大肠埃希菌，并测定其对头孢克肟、头孢噻肟、头孢他啶、头孢曲松、环丙沙星、庆大霉素、亚胺培南和复方新诺明等抗生素的敏感性。结果环丙沙星是最活跃的抗菌剂(易感率77.8%)，其次为庆大霉素(66.4%)。耐药率较高的是头孢克肟(58.5%)和复方新诺明(56.9%)。结论抗菌药物敏感性的调查至关重要，将有助于发现对抗菌药物耐药的大肠埃希菌，利于限制耐药的大肠埃希菌传播。
目的：從兒童體內分離大腸埃希菌，併分析其耐藥狀況。方法本實驗中從未滿18週歲兒童體內分離齣123例大腸埃希菌，併測定其對頭孢剋肟、頭孢噻肟、頭孢他啶、頭孢麯鬆、環丙沙星、慶大黴素、亞胺培南和複方新諾明等抗生素的敏感性。結果環丙沙星是最活躍的抗菌劑(易感率77.8%)，其次為慶大黴素(66.4%)。耐藥率較高的是頭孢剋肟(58.5%)和複方新諾明(56.9%)。結論抗菌藥物敏感性的調查至關重要，將有助于髮現對抗菌藥物耐藥的大腸埃希菌，利于限製耐藥的大腸埃希菌傳播。
목적：종인동체내분리대장애희균，병분석기내약상황。방법본실험중종미만18주세인동체내분리출123례대장애희균，병측정기대두포극우、두포새우、두포타정、두포곡송、배병사성、경대매소、아알배남화복방신낙명등항생소적민감성。결과배병사성시최활약적항균제(역감솔77.8%)，기차위경대매소(66.4%)。내약솔교고적시두포극우(58.5%)화복방신낙명(56.9%)。결론항균약물민감성적조사지관중요，장유조우발현대항균약물내약적대장애희균，리우한제내약적대장애희균전파。
Objective To isolate escherichia coli from children and investigate the drug resistance. MethodsCollected 123 cases of escherichia coli from children and then determined their susceptibility to cefotaxime, cefixime, ceftazidime, ciprofloxacin, ceftriaxone, gentamicin, imipenem, cotrimoxazole. Results Ciprofloxacin was the most effective(77.8% susceptible), followed by drug gentamicin (66.4% susceptible). The most common resistant-drug was cefixime (58.5%) and cotrimoxazole (56.9%).ConclusionThe study drug resistance of escherichia coli is very important in prevention of escherichia coli spread.
